Compile Data Set for Download or QSAR
Report error Found 13 Enz. Inhib. hit(s) with Target = 'Non-receptor tyrosine-protein kinase TYK2 [886-1187]'
TargetNon-receptor tyrosine-protein kinase TYK2 [886-1187](Human)
Array Biopharma

US Patent
LigandPNGBDBM127657(US8791123, 30 | US9782415, Example 30 | US9796724,...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2019
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2 [886-1187](Human)
Array Biopharma

US Patent
LigandPNGBDBM127679(US8791123, 52 | US9782415, Example 52 | US9796724,...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2019
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2 [886-1187](Human)
Array Biopharma

US Patent
LigandPNGBDBM127767(US8791123, 140 | US9782415, Example 140 | US979672...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2019
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2 [886-1187](Human)
Array Biopharma

US Patent
LigandPNGBDBM127720(US8791123, 93 | US9782415, Example 93 | US9796724,...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2019
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2 [886-1187](Human)
Array Biopharma

US Patent
LigandPNGBDBM127733(US8791123, 106 | US9782415, Example 106 | US979672...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2019
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2 [886-1187](Human)
Array Biopharma

US Patent
LigandPNGBDBM127741(US8791123, 114 | US9782415, Example 114 | US979672...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2019
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2 [886-1187](Human)
Array Biopharma

US Patent
LigandPNGBDBM127808(US8791123, 181 | US9782415, Example 181)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2019
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2 [886-1187](Human)
Array Biopharma

US Patent
LigandPNGBDBM127718(US8791123, 91 | US9782415, Example 91 | US9796724,...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2019
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2 [886-1187](Human)
Array Biopharma

US Patent
LigandPNGBDBM127750(US8791123, 123 | US9782415, Example 123 | US979672...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2019
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2 [886-1187](Human)
Array Biopharma

US Patent
LigandPNGBDBM127751(US8791123, 124 | US9782415, Example 124 | US979672...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2019
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2 [886-1187](Human)
Array Biopharma

US Patent
LigandPNGBDBM127817(US8791123, 190 | US9782415, Example 190 | US979672...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2019
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2 [886-1187](Human)
Array Biopharma

US Patent
LigandPNGBDBM127725(US8791123, 98 | US9782415, Example 98 | US9796724,...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2019
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2 [886-1187](Human)
Array Biopharma

US Patent
LigandPNGBDBM127821(US8791123, 194 | US9782415, Example 194 | US979672...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2019
Entry Details
Go to US Patent